Banerjee, A. (2004). Oral gefitinib produces symptomatic and radiological benefit in advanced NSCLC. BMJ Group.
Style de citation ChicagoBanerjee, A. Oral Gefitinib Produces Symptomatic and Radiological Benefit in Advanced NSCLC. BMJ Group, 2004.
Style de citation MLABanerjee, A. Oral Gefitinib Produces Symptomatic and Radiological Benefit in Advanced NSCLC. BMJ Group, 2004.
Attention : ces citations peuvent ne pas être correctes à 100%.